Paper8906986
Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization.
Ahlers JD and 5 others. AIDS Res Hum Retroviruses, 1996. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization. Papers, record 8906986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8906986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| Antibodies, Blocking | Major topic |
| Gene Products, env | Major topic |
| HIV-1 | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Th1 Cells | Major topic |
| Adjuvants, Immunologic | |
| Amino Acid Sequence | |
| Animals | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Molecular Sequence Data | |
| Peptide Fragments | |
| Vaccination |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36679860 | Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36679860 | PubMed |
| 24670321 | Modulation of HIV-1 immunity by adjuvants. | Curr Opin HIV AIDS | 2014 | https://conductscience.org/library/papers/24670321 | PubMed |
| 23653149 | A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602). | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23653149 | PubMed |
| 16636134 | Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. | J Exp Med | 2006 | https://conductscience.org/library/papers/16636134 | PubMed |
| 14512570 | Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized. | J Virol | 2003 | https://conductscience.org/library/papers/14512570 | PubMed |
| 12232042 | A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12232042 | PubMed |
| 11733563 | High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11733563 | PubMed |
| 11726972 | Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. | Nat Med | 2001 | https://conductscience.org/library/papers/11726972 | PubMed |
| 10023333 | AIDS vaccine development: let a thousand flowers bloom. | J Clin Pathol | 1998 | https://conductscience.org/library/papers/10023333 | PubMed |
| 9854042 | The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9854042 | PubMed |
| 9465081 | Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9465081 | PubMed |
| 9420270 | Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1. | J Virol | 1998 | https://conductscience.org/library/papers/9420270 | PubMed |
| 9380724 | Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9380724 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ENPEP | 2028 | PubTator's text mining | https://conductscience.org/library/genes/2028 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8906986
GET https://conductscience.org/api/papers/v1/8906986/authors